All Industries

Top Biotech Companies

3,952 Biotech companies, sorted by total funding raised.

3,952

Companies

$268.5B

Combined Funding

65

Funded (Last 60d)

Series B

Top Stage

Indexed tracks 3,952 Biotech companies that have collectively raised $268.5B in documented funding. The most-funded biotech companies tracked include Parexel and Simtra BioPharma Solutions. 65 companies closed a new round in the last 60 days, with Series B being the most common funding stage.

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private Equity·$5.0B·Jun 2017
Simtra BioPharma Solutions

Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...

Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA

Global fertility clinics platform

Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Altos Labs

Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022
inVentiv HealthAcquired

Biopharmaceutical services company

Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
Warner ChilcottClosed

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
BeiGeneIPO

Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...

Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020
Novotech Holdings

Novotech is a full-service CRO with integrated labs providing clinical drug development services ...

Singapore, Australia1001–5000Biotech, Healthcare
Growth Equity·$2.7B·Mar 2025
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Round·$2.6B·May 2026
AsymchemIPO

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Hugel

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Aesthetics, Biotech
Private Equity·$2.3B·Aug 2021
Calico

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...

South San Francisco, United States201–500Biotech, Healthcare
Corporate Round·$2.3B·Jun 2018
ImmucorAcquired

Blood transfusion and transplant diagnostics company, now operating as a division of Werfen after...

Norcross, United States5001–10000Biotech, Healthcare
Funding undisclosed
Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G+·$1.9B·Nov 2021
BridgeBioIPO

BridgeBio makes targeted treatments for genetic diseases.

San Francisco Bay Area, United States201–500Biotech, Life Sciences
Growth Equity·$1.7B·Jan 2024
P(
Paratek (formerly Transcept Pharmaceuticals)IPO

Paratek Pharmaceuticals is a biopharmaceutical company developing antibiotic therapies based on n...

King of Prussia, United States51–200Biotech, Healthcare
Series C·$1.6B·Jan 2008
Oxford Nanopore Technologies

UK biotech company making portable DNA/RNA nanopore sequencing devices for real-time analysis any...

London, United Kingdom1001–5000Nanopore Sequencing, Biotech
Venture Round·$1.6B·Jan 2024
Abivax SAIPO

Clinical-stage biotechnology company developing therapeutics that harness the body's natural regu...

Paris, France51–200Biotech, Healthcare
Corporate Round·$1.6B·Jan 2025
National Resilience

Contract development and manufacturing organization (CDMO) focused on delivering high-quality bio...

Blue Ash, United States1001–5000Biotech
Venture Round·$1.5B·Jun 2025
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series D·$1.4B·Jun 2020
Kry

European digital healthcare platform connecting patients with licensed doctors via video consulta...

Stockholm, Sweden1001–5000Healthcare, Biotech
Venture Round·$1.4B·Apr 2025
Roivant Sciences

Biotech holding company developing and commercializing medicines across multiple therapeutic areas.

New York, United States201–500Biotech, Healthcare
Growth Equity·$1.3B·Nov 2018
Denali TherapeuticsIPO

Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...

South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$1.3B·Dec 2025
Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021

Frequently Asked Questions

How many Biotech companies are tracked on Indexed?

Indexed tracks 3,952 Biotech companies, sorted by total funding raised.

How much funding have Biotech companies raised in total?

The Biotech companies tracked by Indexed have collectively raised $268.5B in documented funding.

What are the top-funded Biotech companies?

The most-funded Biotech companies tracked include Parexel, Simtra BioPharma Solutions, Pharmaceutical Product Development, Inc. (PPD).

Who are the top investors in Biotech?

Leading investors active in Biotech include Y Combinator Continuity Fund, Techstars, Andreessen Horowitz.

Explore More

Other Industries